Literature DB >> 1903195

fosB is a transforming gene encoding a transcriptional activator.

M Schuermann1, K Jooss, R Müller.   

Abstract

The fosB gene encodes a nuclear protein that shows a high degree of homology with c-Fos in several of the known functionally crucial domains, e.g., the leucine zipper and the DNA-binding site, but shows considerable divergence in other regions. Here, we report that FosB, when placed under the control of a constitutive promoter, exhibits clear transforming properties in focus assays using mouse NIH3T3 or rat 208F fibroblasts. The transforming potential of FosB is considerably stronger than that of a corresponding c-fos construct and resembles that of viral fos genes. Using chimeric fos/fosB constructs we show that the C-terminal half of FosB is responsible for these stronger transforming properties, apparently by giving rise to significantly higher levels of protein as compared with the corresponding c-fos sequence. Surprisingly, substitution of the N-terminus of Fos with that of FosB decreases its transforming potential. These differences in the transforming potential are not related to DNA or protein expression, but rather seem to reflect differences in the molecular function(s) encoded in the N-terminal halves of Fos and FosB protein. Both, fosB- and v-fos transformed cells show increased expression of a number of endogenous genes, including c-jun, transin, alpha 1(III) collagen and tissue plasminogen activator. Transactivation by FosB and v-fos of the c-jun and alpha 1(III) collagen gene promoters and of a 3 x TRE-tk chimeric promoter could be shown in transient CAT assays. v-Fos, but not FosB-transformed cells, also show elevated levels of urokinase and plasminogen activator inhibitor mRNAs, pointing to potential differences in the gene regulatory properties of the two Fos family members.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1903195

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  8 in total

1.  Absence of a persistently elevated 37 kDa fos-related antigen and AP-1-like DNA-binding activity in the brains of kainic acid-treated fosB null mice.

Authors:  A Mandelzys; M A Gruda; R Bravo; J I Morgan
Journal:  J Neurosci       Date:  1997-07-15       Impact factor: 6.167

2.  Analysis of fra-2 gene expression.

Authors:  T Yoshida; T Suzuki; H Sato; H Nishina; H Iba
Journal:  Nucleic Acids Res       Date:  1993-06-11       Impact factor: 16.971

3.  Proto-oncogene FosB: the amino terminus encodes a regulatory function required for transformation.

Authors:  R Wisdom; I M Verma
Journal:  Mol Cell Biol       Date:  1993-05       Impact factor: 4.272

4.  Cell transformation by c-fos requires an extended period of expression and is independent of the cell cycle.

Authors:  G G Miao; T Curran
Journal:  Mol Cell Biol       Date:  1994-06       Impact factor: 4.272

5.  Structure, mapping, and expression of erp, a growth factor-inducible gene encoding a nontransmembrane protein tyrosine phosphatase, and effect of ERP on cell growth.

Authors:  T Noguchi; R Metz; L Chen; M G Mattéi; D Carrasco; R Bravo
Journal:  Mol Cell Biol       Date:  1993-09       Impact factor: 4.272

6.  Existence of different Fos/Jun complexes during the G0-to-G1 transition and during exponential growth in mouse fibroblasts: differential role of Fos proteins.

Authors:  K Kovary; R Bravo
Journal:  Mol Cell Biol       Date:  1992-11       Impact factor: 4.272

7.  An autonomous N-terminal transactivation domain in Fos protein plays a crucial role in transformation.

Authors:  K U Jooss; M Funk; R Müller
Journal:  EMBO J       Date:  1994-03-15       Impact factor: 11.598

8.  The Mos/MAP kinase pathway stabilizes c-Fos by phosphorylation and augments its transforming activity in NIH 3T3 cells.

Authors:  K Okazaki; N Sagata
Journal:  EMBO J       Date:  1995-10-16       Impact factor: 11.598

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.